Global Remote Diagnosis Market to Reach $87 Billion...
“Following UK, Additional European Supply Confirmed”
Accelerating Collaboration with Optimal AI Solutions as Europe Launches Lung Cancer Screenings
Coreline Soft is strengthening its dominance in the AI remote diagnosis market, following last year's partnership with the UK-based teleradiology specialist DMC Healthcare, leveraging its world-class artificial intelligence (AI) technology.
On the 21st, Coreline Soft announced that it has signed a supply contract for its proprietary AI software (SW) with Europe-based remote diagnosis company XCoorp GMBH.
The decision came as XCoorp requested AI SW supply from Coreline Soft due to the surging demand for remote diagnosis in Europe. XCoorp is a remote diagnosis and AI-based imaging diagnosis solution specialist located in Austria. It has a network of numerous hospitals and radiology centers across Europe. In addition to Austria, it collaborates with medical AI companies in Germany, Belgium, and Japan.
Coreline Soft plans to accelerate its global remote diagnosis market expansion starting with the contract with XCoorp. The company recently demonstrated through international academic journals that its AI technology surpasses that of the world's top imaging diagnosis companies. Since the product was developed to integrate the workflow of remote diagnosis companies with AI SW, the company expects adoption to expand.
The global remote diagnosis market is rapidly growing, especially in North America and Europe, driven by a shortage of medical personnel and advancements in AI technology increasing demand for image interpretation. According to market research firm Grand View Research, the related global market size was $15.6 billion (approximately 22 trillion KRW) last year and is projected to grow at an average annual rate of 25.7% to reach $60.3 billion (approximately 87 trillion KRW) by 2030.
A Coreline Soft official said, "Following last year's first contract in the remote diagnosis field with DMC Healthcare, securing supply references for European government projects and proving AI technology through academic papers have accelerated adoption by remote diagnosis companies."
He added, "Due to confidentiality agreements, we cannot disclose specific contract details, but this contract's unit price has more than doubled compared to previous agreements, which further proves Coreline Soft's AI technology's global competitiveness."
Furthermore, he explained, "Starting with this contract, we plan to continue collaborating with XCoorp to expand the applied solutions and AI SW utilization areas," and "Based on the recently introduced AI platform, we will advance AI technology and accelerate our global remote diagnosis market strategy."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
